BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16908800)

  • 1. Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolism.
    Jilma B; Kovar FM; Hron G; Endler G; Marsik CL; Eichinger S; Kyrle PA
    Arch Intern Med; 2006 Aug 14-28; 166(15):1655-9. PubMed ID: 16908800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
    Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Minar E; Lechner K; Kyrle PA
    Thromb Haemost; 1997 Apr; 77(4):624-8. PubMed ID: 9134632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.
    Lindmarker P; Schulman S; Sten-Linder M; Wiman B; Egberg N; Johnsson H
    Thromb Haemost; 1999 May; 81(5):684-9. PubMed ID: 10365737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism.
    Gulesserian T; Hron G; Endler G; Eichinger S; Wagner O; Kyrle PA
    Thromb Haemost; 2006 Jan; 95(1):65-7. PubMed ID: 16543963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism.
    Eichinger S; Weltermann A; Minar E; Stain M; Schönauer V; Schneider B; Kyrle PA
    Arch Intern Med; 2004 Jan; 164(1):92-6. PubMed ID: 14718328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.
    Eichinger S; Heinze G; Jandeck LM; Kyrle PA
    Circulation; 2010 Apr; 121(14):1630-6. PubMed ID: 20351233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis.
    Zee RY; Cook NR; Cheng S; Erlich HA; Lindpaintner K; Ridker PM
    Circulation; 2006 May; 113(18):2193-200. PubMed ID: 16651467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism.
    Ay C; Jungbauer LV; Kaider A; Koder S; Panzer S; Pabinger I; Mannhalter C
    Thromb Haemost; 2008 May; 99(5):899-904. PubMed ID: 18449419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating P-selectin and the risk of recurrent venous thromboembolism.
    Kyrle PA; Hron G; Eichinger S; Wagner O
    Thromb Haemost; 2007 Jun; 97(6):880-3. PubMed ID: 17549288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
    Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
    Bank I; Libourel EJ; Middeldorp S; Van Pampus EC; Koopman MM; Hamulyák K; Prins MH; Van Der Meer J; Büller HR
    Arch Intern Med; 2004 Sep; 164(17):1932-7. PubMed ID: 15451770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
    Lincz LF; Adams MJ; Scorgie FE; Thom J; Baker RI; Seldon M
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):559-64. PubMed ID: 17762532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overweight, obesity, and the risk of recurrent venous thromboembolism.
    Eichinger S; Hron G; Bialonczyk C; Hirschl M; Minar E; Wagner O; Heinze G; Kyrle PA
    Arch Intern Med; 2008 Aug; 168(15):1678-83. PubMed ID: 18695082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prospective study of recurrent venous thromboembolism in a Hispanic population.
    Mello TB; Orsi FL; Montalvao SA; Ozelo MC; de Paula EV; Annichinno-Bizzachi JM
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):660-5. PubMed ID: 20829682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism.
    Beckers MM; Ruven HJ; Haas FJ; Doevendans PA; ten Cate H; Prins MH; Biesma DH
    Eur J Intern Med; 2010 Aug; 21(4):289-92. PubMed ID: 20603037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superficial thrombophlebitis and risk for recurrent venous thromboembolism.
    Schönauer V; Kyrle PA; Weltermann A; Minar E; Bialonczyk C; Hirschl M; Quehenberger P; Schneider B; Partsch H; Eichinger S
    J Vasc Surg; 2003 Apr; 37(4):834-8. PubMed ID: 12663985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.
    Eichinger S; Weltermann A; Mannhalter C; Minar E; Bialonczyk C; Hirschl M; Schönauer V; Lechner K; Kyrle PA
    Arch Intern Med; 2002 Nov; 162(20):2357-60. PubMed ID: 12418950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII.
    Eischer L; Gartner V; Schulman S; Kyrle PA; Eichinger S;
    Ann Hematol; 2009 May; 88(5):485-90. PubMed ID: 18931845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.
    Glynn RJ; Ridker PM; Goldhaber SZ; Zee RY; Buring JE
    Circulation; 2007 Sep; 116(13):1497-503. PubMed ID: 17846285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal.
    Legnani C; Mattarozzi S; Cini M; Cosmi B; Favaretto E; Palareti G
    Br J Haematol; 2006 Jul; 134(2):227-32. PubMed ID: 16846482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.